HIV Mutation Detail Information

> D113A Search Result

Mutation Information

Mutation Site	D113A
Mutation Type	Amino acid level
Gene/Protein/Region Type	RT
Combined Mutation	rt.Q151M+rt.D113A+rt.G112S;rt.F160L+rt.Q151M+rt.F116Y+rt.Y115F+rt.D113A+rt.G112S;rt.F160L+rt.Q151M+rt.V118L+rt.F116Y+rt.Y115F+rt.D113A+rt.G112S;rt.F160L+rt.Q151M+rt.L149I+rt.F116Y+rt.F115Y+rt.D113A+rt.G112S;rt.F160L+rt.I159L+rt.Q151M+rt.F116Y+rt.F115Y+rt.D113A+rt.G112S
Relevant Drug	entecavir (ETV);lamivudine (LAM);tenofovir alafenamide (TAF);islatravir (ISL);zidovudine (AZT)

Literature Information

PubMed PMID	32080249
Published Year	2020
Journal	Scientific reports
Title	Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudine.
Author	Yasutake Y,Hattori SI,Tamura N,Matsuda K,Kohgo S,Maeda K,Mitsuya H
Evidence	Table 1

Contents
Description

Mutation Information Note

Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)

Literature Information Note

Evidence: sentence contains this mutation information in the citation